Among more than 2,000 patients who completed a TDScreen assessment, 156 received a Tardive Dyskinesia diagnosis and 125 were prescribed treatment, real-world evidence that AI-enabled screening is ...

The first expert consensus recommendations centered on screening, diagnosing and screening tardive dyskinesia (TD) among older adults in long-term care settings were presented at the Society for ...

Tardive dyskinesia, or TD, is a drug-induced movement disorder that can occur in individuals taking certain medications that block dopamine receptors in the brain. Most commonly, cases of TD are ...

Expert panel establishes structured approach to tardive dyskinesia screening, diagnosis and treatment in long-term care, including use of VMAT2 inhibitors New post-hoc KINECT‑PRO™ analysis in adults ...

SAN DIEGO, May 5, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc (NBIX). (Nasdaq: NBIX) today announced the release of findings from a new survey conducted by The Harris Poll highlighting the ...

SAN DIEGO, March 26, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of the first expert consensus recommendations focused on screening, diagnosis and ...

-- Majority of individuals polled reported tardive dyskinesia negatively impacts their day-to-day ability to function, including individuals living with mild or moderate uncontrolled movements1 SAN ...